Charles Russell Speechlys’ corporate team powers up the AIM adviser rankings
Charles Russell Speechlys is pleased to note the continued advance up the rankings in many key sectors in the Adviser Rankings Guide – April 2016. As a firm committed to entrepreneurs and their businesses, we are pleased to continue to be recognised for the contribution we are making as advisers to AIM clients. Our corporate advice for clients on the AIM market has been recognised by our move upwards to 8th from 13th place for total AIM clients and has once again highlighted our allegiance to the AIM market. In fact, we are pleased to have completed three IPOs on the AIM market during the first quarter of this year.
Advancing to 4th place specifically for Technology clients shows our commitment to the Technology, Media and Telecoms sector supporting businesses through their life cycle. By way of example, we have continued to advise Tekcapital PLC on all its continued growth cycle since IPO.
We have seen increased rankings within other core sectors including, Basic Materials, Financial Services, Industrial and a new entry into the Healthcare category, where we have well established relationships with CareTech Holdings PLC and Bioventis PLC. As legal advisers to CareTech Holdings PLC, a leading provider of specialist social care services in the UK, for over 20 years, we recently advised them on a conditional £21m placing of new shares and continue to advise on the extension and amendment to the terms of its £165m group senior debt facilities and for recent acquisitions.
Clive Hopewell, Partner and head of the Capital Markets group, said, “ This has been a challenging quarter for AIM and the team has been working hard to maximise return for clients on the market. Being recognised for our continued commitment to the AIM community is important to us, not only as recognition for our expertise but also for the wider support we give in terms of our training, our role with ELITE and to SMEs considering the AIM market as an option for their future growth. ”
News & Insights
Charles Russell Speechlys advises Taptica International Ltd on recommended all-share acquisition of AIM listed RhythmOne
Taptica is an AIM listed global advertising technologies platform provider.
Charles Russell Speechlys advises on two Capital Markets deals announced in two days
The team advised Transense Technologies Plc, and joint brokers WH Ireland, Canaccord Genuity and First Energy Capital.
Charles Russell Speechlys advises Vapotherm on the acquisition of Solus Medical
Vapotherm is a publicly traded developer and manufacturer of advanced respiratory technology.